{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:43:21Z","timestamp":1783651401458,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.drugpo.2007.01.013","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:16:43Z","timestamp":1172060203000},"page":"417-425","source":"Crossref","is-referenced-by-count":47,"title":["Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach"],"prefix":"10.1016","volume":"18","author":[{"given":"Guthrie S.","family":"Birkhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma R.","family":"Candelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira S.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Cotroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2007.01.013_bib1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00042560-199802001-00003","article-title":"The importance of preventing hepatitis C virus infection among injection drug users in the United States","volume":"18","author":"Alter","year":"1998","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"issue":"10","key":"10.1016\/j.drugpo.2007.01.013_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2007.01.013_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/jhep.2001.25882","article-title":"Treatment of hepatitis C infection in injection drug users","volume":"34","author":"Backmund","year":"2001","journal-title":"Hepatology"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2007.01.013_bib4","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1086\/427475","article-title":"Hepatitis C virus infection and injection drug users: Prevention, risk factors and treatment","volume":"40","author":"Backmund","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2007.01.013_bib5","series-title":"XVI international AIDS conference","article-title":"Evaluation of a public\u2013private partnership for syringe access and safe disposal","author":"Battles","year":"2006"},{"key":"10.1016\/j.drugpo.2007.01.013_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with Human Immunodeficiency Virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2007.01.013_bib7","unstructured":"Candelas, A.R. (1997). USA New York State promotes the harm reduction approach. AIDS\/STD health promotion exchange, 2. Available at: http:\/\/www.kit.nl\/frameset.asp?\/ils\/exchange_content\/html\/index_country.asp&frnr=1&."},{"key":"10.1016\/j.drugpo.2007.01.013_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.321.7265.899","article-title":"Minimizing harm from hepatitis C virus needs better strategies","volume":"321","author":"Crofts","year":"2000","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1016\/j.drugpo.2007.01.013_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM200107193450312","article-title":"Treatment of chronic hepatitis C in active drug users","volume":"345","author":"Davis","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.drugpo.2007.01.013_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0955-3959(03)00137-3","article-title":"Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA","volume":"14","author":"Deren","year":"2003","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2007.01.013_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(96)02536-6","article-title":"HIV incidence among injecting drug users in New York City syringe-exchange programs","volume":"348","author":"Des Jarlais","year":"1996","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2007.01.013_bib12","series-title":"Presented at the conference of the American Public Health Association","article-title":"New York City syringe evaluation: The New York City syringe exchange program: Evaluation of a public health initiative","author":"Des Jarlais","year":"1994"},{"issue":"Suppl. 3","key":"10.1016\/j.drugpo.2007.01.013_bib13","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000192066.86410.8c","article-title":"Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990\u20132001","volume":"19","author":"Des Jarlais","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2007.01.013_bib14","doi-asserted-by":"crossref","unstructured":"Edlin, B. R. (2002). Prevention and treatment of hepatitis C in injection drug users. Hepatology, 36(5)(Suppl. 1), S210\u2013S219.","DOI":"10.1002\/hep.1840360727"},{"key":"10.1016\/j.drugpo.2007.01.013_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/499960","article-title":"Injection drug users: The overlooked core of the hepatitis C epidemic","volume":"42","author":"Edlin","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2007.01.013_bib16","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1086\/427441","article-title":"Overcoming barriers to prevention, care, and treatment of hepatitis C in injection drug users","volume":"40","author":"Edlin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"5\u20136","key":"10.1016\/j.drugpo.2007.01.013_bib17","first-page":"423","article-title":"HIV and HCV infection among injecting drug users","volume":"67","author":"Hagan","year":"2000","journal-title":"The Mount Sinai Journal of Medicine"},{"key":"10.1016\/j.drugpo.2007.01.013_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/499951","article-title":"Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 U.S. cities","volume":"42","author":"Hagan","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2007.01.013_bib19","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1086\/427444","article-title":"Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection","volume":"40","author":"Hagan","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2007.01.013_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"American Journal of Public Health"},{"issue":"4","key":"10.1016\/j.drugpo.2007.01.013_bib21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF02344036","article-title":"Commentary: Expanded Syringe Access Demonstration Program (ESAP) in New York State (NYS): An intervention to prevent HIV transmission","volume":"77","author":"Klein","year":"2000","journal-title":"Journal of Urban Health"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2007.01.013_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1331\/1086-5802.42.0.S105.Klein","article-title":"Promoting safe syringe disposal goes \u201chand in hand\u201d with expanded syringe access in New York State","volume":"42","author":"Klein","year":"2002","journal-title":"Journal of the American Pharmaceutical Association"},{"key":"10.1016\/j.drugpo.2007.01.013_bib23","unstructured":"Klein, S. J., Wright, L. N., Birkhead, G. S., Mojica, B. A., Klopf, L. C., Klein, L. A., et al. (in press). Promoting HCV treatment completion for prison inmates: New York State's Hepatitis C Continuity Program. Public Health Reports."},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2007.01.013_bib24","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1086\/427450","article-title":"Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: Challenges and opportunities","volume":"40","author":"Litwin","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"Fall","key":"10.1016\/j.drugpo.2007.01.013_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/002204260403400407","article-title":"Drug treatment programs as sites of opportunity for the delivery of hepatitis C prevention education: Client and staff perspectives","author":"Munoz-Plaza","year":"2004","journal-title":"The Journal of Drug Issues"},{"key":"10.1016\/j.drugpo.2007.01.013_bib26","unstructured":"National Institutes of Health (NIH). (2002). NIH consensus statement on management of hepatitis C: 2002. NIH consensus and state-of-the-science statements, 19(3). Available at: http:\/\/consensus.nih.gov\/2002\/2002HepatitisC2002116PDF.pdf Accessed January 23, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib27","series-title":"HUB system: Profile of inmate population under custody on January 1, 2004","author":"New York State Department of Correctional Services","year":"2005"},{"key":"10.1016\/j.drugpo.2007.01.013_bib28","unstructured":"New York State Department of Health. (2004). Viral Hepatitis Strategic Plan, June 2004. Albany, NY: New York State Department of Health. Available at: http:\/\/www.health.state.ny.us\/diseases\/communicable\/hepatitis\/strategic\/index.htm Accessed July 19, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib29","unstructured":"New York State Department of Health. (2005a). 2005 annual chronic hepatitis surveillance report. Available at: http:\/\/www.health.state.ny.us\/diseases\/communicable\/hepatitis\/docs\/hbv_hepc_chronic_report_2005.pdf Accessed August 14, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib30","unstructured":"New York State Department of Health. (2005b). Clinical guidelines for the management of hepatitis C, 2005. Albany, NY: New York State Department of Health. Available at: http:\/\/www.health.state.ny.us\/diseases\/communicable\/hepatitis\/guidelines\/index.htm Accessed July 19, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib31","unstructured":"New York State Department of Health. (2006). New York State HIV\/AIDS surveillance semiannual report for cases diagnosed through December 2004, April 2006. Albany, NY: New York State Department of Health. Available at: http:\/\/www.health.state.ny.us\/diseases\/aids\/statistics\/semiannual\/2004\/surveillance_semiannual_report_2004_december.pdf Accessed July 24, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib32","unstructured":"New York State Department of Health, AIDS Institute, Office of the Medical Director. (2004). Hepatitis C virus. Available at: http:\/\/www.hivguidelines.org\/GuideLine.aspx?pageID=257&guideLineID=17 Accessed August 8, 2006."},{"issue":"4","key":"10.1016\/j.drugpo.2007.01.013_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.qai.0000152395.82885.c0","article-title":"Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program","volume":"39","author":"Pouget","year":"2005","journal-title":"JAIDS"},{"key":"10.1016\/j.drugpo.2007.01.013_bib34","series-title":"The XV international AIDS conference, 2004","article-title":"Addressing hepatitis C through HIV prevention services for injection drug users: Program development and policy considerations","author":"Raymond","year":"2004"},{"key":"10.1016\/j.drugpo.2007.01.013_bib35","unstructured":"Rothman, J. R., Birkhead, G., Rudnick, D., Slifer, M., Agins, B., & Heiner, K. (in press). Co-located substance use treatment and HIV prevention and primary care services; New York State, 1990\u20132002: A model for effective service delivery to a high risk population. Journal of Urban Health."},{"key":"10.1016\/j.drugpo.2007.01.013_bib36","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1097\/00002030-200110190-00014","article-title":"Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: A case\u2013control study","volume":"15","author":"Serfaty","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2007.01.013_bib37","unstructured":"Stancliff, S., Agins, B., Rich, J. D., & Burris, S. (2003). Syringe access for the prevention of blood borne infections among injection drug users. BMC public health. Available at: http:\/\/www.biomedcentral.com\/1471-2458\/3\/37 Accessed July 26, 2006."},{"issue":"4","key":"10.1016\/j.drugpo.2007.01.013_bib38","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl. 3","key":"10.1016\/j.drugpo.2007.01.013_bib39","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/01.aids.0000192064.09281.48","article-title":"Perspectives on HIV\/hepatitis C virus co-infection, illicit drug use and mental illness","volume":"19","author":"Sulkowski","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2007.01.013_bib40","series-title":"Evidence based policy and practice: 133rd annual meeting of the American Public Health Association","article-title":"Assessment of New York's Expanded Syringe Access Demonstration Program: Results from statewide baseline and follow-up surveys of physicians","author":"Tesoriero","year":"2005"},{"key":"10.1016\/j.drugpo.2007.01.013_bib41","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institute on Drug Abuse and Substance Abuse and Mental Health Services Administration. (1997). HIV prevention bulletin: Medical advice for persons who inject illicit drugs. May 9, 1997. Available at: http:\/\/www.cdc.gov\/idu\/pubs\/hiv_prev.htm Accessed July 25, 2006."},{"key":"10.1016\/j.drugpo.2007.01.013_bib42","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity mortality weekly report, 47(RR-19), pp. 1\u201340."},{"key":"10.1016\/j.drugpo.2007.01.013_bib43","series-title":"National hepatitis C prevention strategy","author":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention","year":"2001"},{"key":"10.1016\/j.drugpo.2007.01.013_bib44","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. (2001b). Public health and injection drug use. Morbidity mortality weekly report, 50(19), p. 377."},{"key":"10.1016\/j.drugpo.2007.01.013_bib45","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. (2003). Prevention and control of infections with hepatitis viruses in correctional settings. Morbidity mortality weekly report, 52(RR-9), pp. 1\u201335."},{"key":"10.1016\/j.drugpo.2007.01.013_bib46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/10826080600669579","article-title":"Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of international evidence","volume":"41","author":"Wodak","year":"2006","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2007.01.013_bib47","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality, and costs in the United States","volume":"90","author":"Wong","year":"2000","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2007.01.013_bib48","series-title":"The American Conference for the Treatment of HIV (ACTHIV)","article-title":"The Montefiore HIV\/HCV co-infection program: 18-month results from an expert multidisciplinary team co-located at an urban HIV primary care clinic","author":"Zingman","year":"2005"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539590700014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539590700014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:56:22Z","timestamp":1736812582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095539590700014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S095539590700014X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2007.01.013","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}